Metabolic / GLP-1
GOD Stack
A three-component metabolic recomposition stack combining the triple agonist Retatrutide with the mitochondrial peptide MOTS-c and the visceral-fat-targeted GHRH analog Tesamorelin.
Quick facts
Molecular weight
4,731 Da
Half-life
144 h
Frequency
weekly
Admins / wk
1
Routes
SubQ
Typical dose
500 mcg–12.0 mg
Mechanism & positioning
A three-component metabolic recomposition stack combining the triple agonist Retatrutide with the mitochondrial peptide MOTS-c and the visceral-fat-targeted GHRH analog Tesamorelin.
Researched for: triple-receptor incretin agonism, mitochondrial function, visceral adipose reduction.
Blend composition
| Component | Mass in vial | % of blend | |
|---|---|---|---|
| Retatrutide | 40 mg | 66.7% | Profile |
| MOTS-c | 10 mg | 16.7% | Profile |
| Tesamorelin | 10 mg | 16.7% | Profile |
Reconstitution defaults
Default vial
60 mg
BAC water
3 mL
Concentration
20000 mcg/mL
Doses per vial
~120
Calculate with this peptide
Dosage Calculator
Pre-filled for 500 mcg from a 60 mg vial in 3 mL BAC water.
Reconstitution Calculator
Auto-fills 60 mg + 3 mL BAC water + 500 mcg target dose.
Half-Life Calculator
Simulates steady-state at 500 mcg weekly.
Titration Schedule Builder
Stepwise escalation from 500 mcg to 12.0 mg.
Stack Builder
Plots the per-component weekly schedule for the 3-peptide blend.
Related peptides in the Metabolic / GLP-1 class
Semaglutide
A long-acting GLP-1 receptor agonist researched for its role in glucose-dependent insulin secretion and reduced gastric emptying.
Tirzepatide
A dual GIP and GLP-1 receptor agonist investigated for superior weight and glycaemic outcomes versus selective GLP-1 agonists.
Retatrutide
A triple agonist of GIP, GLP-1, and glucagon receptors currently in late-phase research for obesity and metabolic indications.
AOD-9604
A fragment of the C-terminus of human GH researched for stimulating lipolysis without affecting blood glucose or IGF-1.
SLU-PP-332
A small-molecule pan-ERR agonist investigated in preclinical models for inducing exercise-mimetic mitochondrial gene expression in muscle and adipose tissue.
5-Amino-1MQ
A small-molecule selective NNMT inhibitor investigated in preclinical models for reducing methyl-group sequestration in adipose tissue and restoring NAD+/SAM balance.